Get the Stockscreener App
0.0042
8.70%
-0.0004
Pharmagreen Biotech Inc Stock (PHBI) Forecast
The Pharmagreen Biotech Inc (PHBI) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $0.00477, representing a +13.53% increase from the current price of $0.0042. The highest analyst price target is $0.00633, and the lowest is $0.00321.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month PHBI Price Target
Average 0.00791
(+88.43% Upside)
Long-term PHBI price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Pharmagreen Biotech Inc financial reports and earnings history, Pharmagreen Biotech Inc (PHBI) stock could reach $0.0314 by 2030, $0.1101 by 2040 and $0.1213 by 2050. See the projected annual prices until 2050 of the Pharmagreen Biotech Inc stock below:
- Pharmagreen Biotech Inc (PHBI) is expected to reach an average price of $0.0637 in 2035, with a high prediction of $0.0712 and a low estimate of $0.0662. This indicates an $1,417% rise from the last recorded price of $0.0042.
- Pharmagreen Biotech Inc (PHBI) stock is projected to chart a bullish course in 2040, with an average price target of $0.1032, representing an $2,358% surge from its current level. The forecast ranges from a conservative $0.1032 to a sky-high $0.1101.
- Our analysts predict Pharmagreen Biotech Inc (PHBI) to jump 3,310% by 2045, soaring from $0.0893 to an average price of $0.1432, potentially reaching $0.147. While $0.0893 is the low estimate, the potential upside is significant.
- Pharmagreen Biotech Inc (PHBI) stock is expected to climb by 2050, reaching an average of $0.1161, a $2,664% jump from its current level. However, a wide range of estimates exists, with high and low targets of $0.1213 and $0.1109, respectively, highlighting the market's uncertainty.
Pharmagreen Biotech Inc Stock (PHBI) Year by Year Forecast
Pharmagreen Biotech Inc Stock (PHBI) Price Forecast for 2024
Our forecast for PHBI stock price in 2024 now indicates an average price target of $0.00353 with a high forecast of $0.00686 and a low forecast of $0.000196. The average prediction reflects an decrease of -16.02% from the last recorded price of $0.0042.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| October, 2024 | $0.00723 | $0.00321 | $0.00633 | +72.14% |
| November, 2024 | $0.00655 | $0.00655 | $0.00606 | +55.95% |
| December, 2024 | $0.0033 | $0.00417 | $0.00538 | -21.44% |
Pharmagreen Biotech Inc Stock (PHBI) Price Forecast for 2025
Pharmagreen Biotech Inc Stock (PHBI) is expected to reach an average price of $0.00889 in 2025, with a high prediction of $0.0126 and a low estimate of $0.00516. This indicates an +111.74% rise from the last recorded price of $0.0042.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $0.00472 | $0.00622 | $0.00393 | +12.37% |
| February, 2025 | $0.00514 | $0.00518 | $0.00385 | +22.36% |
| March, 2025 | $0.00463 | $0.00516 | $0.0041 | +10.28% |
| April, 2025 | $0.00893 | $0.0104 | $0.00948 | +112.57% |
| May, 2025 | $0.00813 | $0.00916 | $0.0085 | +93.61% |
| June, 2025 | $0.00551 | $0.00688 | $0.00531 | +31.22% |
| July, 2025 | $0.00632 | $0.00752 | $0.00637 | +50.36% |
| August, 2025 | $0.00657 | $0.00749 | $0.00622 | +56.40% |
| September, 2025 | $0.0135 | $0.00712 | $0.0126 | +221.95% |
| October, 2025 | $0.0124 | $0.0124 | $0.0122 | +195.47% |
| November, 2025 | $0.0069 | $0.0096 | $0.0111 | +64.23% |
| December, 2025 | $0.00961 | $0.0111 | $0.00882 | +128.74% |
Pharmagreen Biotech Inc Stock (PHBI) Price Forecast for 2026
The predicted value for Pharmagreen Biotech Inc (PHBI) in 2026 is set at an average of $0.014. Estimates vary from a peak of $0.019 to a trough of $0.00908, indicating an +234.28% surge from the present price of $0.0042.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.00959 | $0.00972 | $0.00863 | +128.45% |
| February, 2026 | $0.00758 | $0.00958 | $0.00834 | +80.54% |
| March, 2026 | $0.015 | $0.00908 | $0.0158 | +257.23% |
| April, 2026 | $0.0138 | $0.0149 | $0.0145 | +227.99% |
| May, 2026 | $0.0109 | $0.0123 | $0.00985 | +160.65% |
| June, 2026 | $0.011 | $0.0122 | $0.0113 | +161.59% |
| July, 2026 | $0.0108 | $0.0119 | $0.0105 | +157.35% |
| August, 2026 | $0.0198 | $0.011 | $0.019 | +371.76% |
| September, 2026 | $0.0183 | $0.0183 | $0.0184 | +334.99% |
| October, 2026 | $0.0123 | $0.015 | $0.0169 | +193.46% |
| November, 2026 | $0.0145 | $0.016 | $0.0137 | +245.12% |
| December, 2026 | $0.0141 | $0.0142 | $0.0134 | +234.54% |
Pharmagreen Biotech Inc Stock (PHBI) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Pharmagreen Biotech Inc (PHBI) is $0.0192, with a high forecast of $0.0254 and a low forecast of $0.013. This indicates an +357.09% increase from the last price of $0.0042.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.0116 | $0.0136 | $0.0126 | +176.34% |
| February, 2027 | $0.0226 | $0.013 | $0.0222 | +438.57% |
| March, 2027 | $0.0194 | $0.0207 | $0.021 | +362.37% |
| April, 2027 | $0.0162 | $0.0177 | $0.0151 | +284.74% |
| May, 2027 | $0.0157 | $0.0169 | $0.0161 | +272.82% |
| June, 2027 | $0.015 | $0.0164 | $0.0147 | +258.29% |
| July, 2027 | $0.0273 | $0.015 | $0.0254 | +550.00% |
| August, 2027 | $0.0241 | $0.0241 | $0.0252 | +474.51% |
| September, 2027 | $0.0178 | $0.0205 | $0.0226 | +322.69% |
| October, 2027 | $0.0197 | $0.0221 | $0.0181 | +367.90% |
| November, 2027 | $0.0185 | $0.0186 | $0.0186 | +340.63% |
| December, 2027 | $0.0156 | $0.0176 | $0.0169 | +272.14% |
Pharmagreen Biotech Inc Stock (PHBI) Price Forecast for 2028
In 2028, Pharmagreen Biotech Inc (PHBI) is projected to reach an average price of $0.026, with a high projection of $0.035 and a low estimate of $0.0169. This indicates an +517.99% rise from the last price of $0.0042.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.0272 | $0.0169 | $0.0286 | +546.56% |
| February, 2028 | $0.0251 | $0.0264 | $0.0264 | +496.75% |
| March, 2028 | $0.0214 | $0.0232 | $0.0204 | +408.83% |
| April, 2028 | $0.0222 | $0.0222 | $0.021 | +428.06% |
| May, 2028 | $0.0193 | $0.0209 | $0.0197 | +359.24% |
| June, 2028 | $0.0337 | $0.0189 | $0.0318 | +702.38% |
| July, 2028 | $0.03 | $0.03 | $0.0315 | +614.03% |
| August, 2028 | $0.0232 | $0.0259 | $0.0284 | +451.93% |
| September, 2028 | $0.0246 | $0.0271 | $0.0232 | +486.85% |
| October, 2028 | $0.023 | $0.0231 | $0.0235 | +446.71% |
| November, 2028 | $0.0197 | $0.0217 | $0.0213 | +367.94% |
| December, 2028 | $0.035 | $0.0208 | $0.035 | +733.04% |
Pharmagreen Biotech Inc Stock (PHBI) Price Forecast for 2029
The 2029 price forecast for Pharmagreen Biotech Inc Stock (PHBI) is $0.0321 on average, with a high prediction of $0.0414 and a low estimate of $0.0228. This represents an +664.10% increase from the previous price of $0.0042.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.0307 | $0.0322 | $0.0331 | +631.12% |
| February, 2029 | $0.0266 | $0.0286 | $0.0259 | +532.92% |
| March, 2029 | $0.027 | $0.027 | $0.0259 | +541.86% |
| April, 2029 | $0.0235 | $0.0253 | $0.0244 | +460.18% |
| May, 2029 | $0.0401 | $0.0228 | $0.0382 | +854.76% |
| June, 2029 | $0.0361 | $0.0374 | $0.0378 | +758.56% |
| July, 2029 | $0.0286 | $0.0313 | $0.0345 | +581.16% |
| August, 2029 | $0.0296 | $0.0321 | $0.0283 | +605.79% |
| September, 2029 | $0.0266 | $0.0285 | $0.0284 | +532.81% |
| October, 2029 | $0.0237 | $0.0257 | $0.0256 | +463.74% |
| November, 2029 | $0.0412 | $0.0247 | $0.0414 | +880.28% |
| December, 2029 | $0.0364 | $0.0379 | $0.0392 | +765.50% |
Pharmagreen Biotech Inc Stock (PHBI) Price Forecast for 2030
Pharmagreen Biotech Inc Stock (PHBI) is expected to reach an average price of $0.0372 in 2030, with a high forecast of $0.0478 and a low forecast of $0.0267. This signifies an +786.90% surge from the last price of $0.0042.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.0318 | $0.034 | $0.0314 | +657.01% |
| February, 2030 | $0.0317 | $0.0317 | $0.0308 | +655.67% |
| March, 2030 | $0.0294 | $0.0298 | $0.0291 | +599.56% |
| April, 2030 | $0.0465 | $0.0267 | $0.0446 | +1,007% |
| May, 2030 | $0.042 | $0.0433 | $0.0441 | +900.65% |
| June, 2030 | $0.0361 | $0.0386 | $0.0404 | +758.45% |
| July, 2030 | $0.0346 | $0.0367 | $0.0334 | +724.74% |
| August, 2030 | $0.0311 | $0.0332 | $0.0333 | +641.47% |
| September, 2030 | $0.0277 | $0.0297 | $0.03 | +559.54% |
| October, 2030 | $0.0474 | $0.0287 | $0.0478 | +1,028% |
| November, 2030 | $0.0428 | $0.0437 | $0.0453 | +918.26% |
| December, 2030 | $0.037 | $0.0395 | $0.0417 | +781.10% |
0.11%
0.31%
Cap:
|
Volume (24h):